NCT02788981
Breast Cancer Type: Triple Negative
Hormone Mutations: GR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 2
Drug Category: Endocrine (Hormone Therapy, Chemotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult), Senior)
Location of Metastases: 
Additional Notes: Tumor must also be GR+
Exclusions: Patients with known brain metastases will be eligible, but conditions apply- see trial for details
https://ClinicalTrials.gov/show/NCT02788981